Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy

AIMS: We sought to clarify the role of ventriculo–arterial (V–A) coupling in the treatment of nonischemic dilated cardiomyopathy (NIDCM) by adding a mineralocorticoid receptor antagonist (MRA) to conventional anti‐failure therapy. METHODS AND RESULTS: We employed cardiac magnetic resonance imaging t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawson, Mark A., Hansen, David E., Gupta, Deepak K., Bell, Susan P., Adkisson, Douglas W., Mallugari, Ravinder R., Sawyer, Douglas B., Ooi, Henry, Kronenberg, Marvin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006677/
https://www.ncbi.nlm.nih.gov/pubmed/33403831
http://dx.doi.org/10.1002/ehf2.13161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006677/
https://www.ncbi.nlm.nih.gov/pubmed/33403831
http://dx.doi.org/10.1002/ehf2.13161

Ejemplares similares